Salvatore Serravalle
Bologna, 40126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 05, 2023
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.
Journal: Scientific reports
Published: August 29, 2023
Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax.
Journal: British journal of haematology
Published: March 20, 2023
Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK).
Journal: International journal of molecular sciences
Published: January 16, 2023
Are Induced Pluripotent Stem Cells a Step towards Modeling Pediatric Leukemias?
Journal: Cells
Published: December 29, 2021
Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation.
Journal: Communications biology
Published: November 17, 2021
The Pediatric Acute Leukemia Fusion Oncogene ETO2-GLIS2 Increases Self-Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells-Derived Model.
Journal: HemaSphere
Published: August 05, 2019
Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue.
Journal: Oncotarget
Published: April 05, 2017
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma.
Journal: Genes, chromosomes & cancer
Published: February 03, 2017
Last Updated: 09/26/2026